Comparative Effectiveness of Various Eradication Regimens for Helicobacter Pylori Infection in the Northeastern Region of Poland
Due to the lack of systematic data on antibiotic sensitivity, the treatment of the highly prevalent and pathogenic ( ) infection still poses a significant problem. Therefore, the aim of our study was to compare the efficacy of the three most commonly used anti- therapies in northeastern Poland. This...
Gespeichert in:
| Veröffentlicht in: | International journal of environmental research and public health 2022-06, Vol.19 (11), p.6921 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 11 |
| container_start_page | 6921 |
| container_title | International journal of environmental research and public health |
| container_volume | 19 |
| creator | Wasielica-Berger, Justyna Gugnacki, Patryk Mlynarczyk, Maryla Rogalski, Pawel Swidnicka-Siergiejko, Agnieszka Antonowicz, Stefania Krzyzak, Michalina Maslach, Dominik Dabrowski, Andrzej Daniluk, Jaroslaw |
| description | Due to the lack of systematic data on antibiotic sensitivity, the treatment of the highly prevalent and pathogenic
(
) infection still poses a significant problem. Therefore, the aim of our study was to compare the efficacy of the three most commonly used anti-
therapies in northeastern Poland.
This was a retrospective, single-center study performed on 289 outpatients with an
infection. Patients received one of the following three treatment regimens: (1) bismuth quadruple therapy (BQT) for 10 days, (2) metronidazole-based triple therapy (M-TT) for 10 or 14 days, and (3) levofloxacin-based triple therapy (L-TT) for 10 or 14 days.
BQT, M-TT, and L-TT accounted for 93.2% of prescribed anti-
therapies. The overall success rate for all treatment regimens was 84.1% (243/289). The effectiveness of first- and second-line therapy was similar and reached 83.8% and 86.2%, respectively. The efficacy of the individual treatment regimens was as follows: (1) BQT-89.4% (84/94), (2) M-TT-80.6% (112/139) and 78.8% (26/33) for 10 and 14 days, respectively, and (3) L-TT-84.6% (11/13) and 100% (10/10) for 10 and 14 days, respectively. The overall duration of treatment and type and dose of proton pump inhibitor (PPI) had no effect on the treatment efficacy.
In the northeastern part of Poland, 10-day BQT and 10- or 14-day L-TT are effective treatment regimens for
eradication and have appear to be superior to M-TT. Practitioners in our clinic followed mostly local anti-
therapy guidelines. |
| doi_str_mv | 10.3390/ijerph19116921 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9180243</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2675608378</sourcerecordid><originalsourceid>FETCH-LOGICAL-c418t-342acb2ccad6ccbcbaf4b08c9fe5271448bf2f4e97e17e1827bde12147a6613c3</originalsourceid><addsrcrecordid>eNpdkctLJDEQxoOs-L56XAJ72ctoXpNOXxZkGB8gKqJeQzpdcTJ0J2PSI3jbP92Mo6JCoArqVx_56kPokJIjzmty7OeQFjNaUyprRjfQDpWSjIQk9NeXfhvt5jwnhCsh6y20zcdSsTERO-j_JPYLk8zgnwFPnQO76gLkjKPDDyb5uMx4mkzrbYFiwLfw6HsIGbuY8Dl03sbG2AESvnnpYvL4IrypFNQHPMwAX8VUismFWa-XURG_iZ0J7T7adKbLcPBe99D96fRucj66vD67mJxcjqygahhxwYxtmLWmldY2tjFONETZ2sGYVVQI1TjmBNQV0PIUq5oWKKOiMlJSbvke-rfWXSybHloLYUim04vke5NedDRef58EP9OP8VnXVBEmeBH4-y6Q4tMS8qB7ny10xQSUG2kmq7EkileqoH9-oPO4TKHYW1GCl8tLWaijNWVTzDmB-_wMJXoVrv4ebln4_dXCJ_6RJn8F3hCkpw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2674350466</pqid></control><display><type>article</type><title>Comparative Effectiveness of Various Eradication Regimens for Helicobacter Pylori Infection in the Northeastern Region of Poland</title><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><source>PubMed Central Open Access</source><creator>Wasielica-Berger, Justyna ; Gugnacki, Patryk ; Mlynarczyk, Maryla ; Rogalski, Pawel ; Swidnicka-Siergiejko, Agnieszka ; Antonowicz, Stefania ; Krzyzak, Michalina ; Maslach, Dominik ; Dabrowski, Andrzej ; Daniluk, Jaroslaw</creator><creatorcontrib>Wasielica-Berger, Justyna ; Gugnacki, Patryk ; Mlynarczyk, Maryla ; Rogalski, Pawel ; Swidnicka-Siergiejko, Agnieszka ; Antonowicz, Stefania ; Krzyzak, Michalina ; Maslach, Dominik ; Dabrowski, Andrzej ; Daniluk, Jaroslaw</creatorcontrib><description>Due to the lack of systematic data on antibiotic sensitivity, the treatment of the highly prevalent and pathogenic
(
) infection still poses a significant problem. Therefore, the aim of our study was to compare the efficacy of the three most commonly used anti-
therapies in northeastern Poland.
This was a retrospective, single-center study performed on 289 outpatients with an
infection. Patients received one of the following three treatment regimens: (1) bismuth quadruple therapy (BQT) for 10 days, (2) metronidazole-based triple therapy (M-TT) for 10 or 14 days, and (3) levofloxacin-based triple therapy (L-TT) for 10 or 14 days.
BQT, M-TT, and L-TT accounted for 93.2% of prescribed anti-
therapies. The overall success rate for all treatment regimens was 84.1% (243/289). The effectiveness of first- and second-line therapy was similar and reached 83.8% and 86.2%, respectively. The efficacy of the individual treatment regimens was as follows: (1) BQT-89.4% (84/94), (2) M-TT-80.6% (112/139) and 78.8% (26/33) for 10 and 14 days, respectively, and (3) L-TT-84.6% (11/13) and 100% (10/10) for 10 and 14 days, respectively. The overall duration of treatment and type and dose of proton pump inhibitor (PPI) had no effect on the treatment efficacy.
In the northeastern part of Poland, 10-day BQT and 10- or 14-day L-TT are effective treatment regimens for
eradication and have appear to be superior to M-TT. Practitioners in our clinic followed mostly local anti-
therapy guidelines.</description><identifier>ISSN: 1660-4601</identifier><identifier>ISSN: 1661-7827</identifier><identifier>EISSN: 1660-4601</identifier><identifier>DOI: 10.3390/ijerph19116921</identifier><identifier>PMID: 35682504</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Anti-Bacterial Agents - pharmacology ; Antibiotics ; Antibodies ; Antigens ; Bacterial infections ; Bismuth ; Bismuth - therapeutic use ; Cancer therapies ; Drug Therapy, Combination ; Endoscopy ; Eradication ; Gastric cancer ; Gastroenterology ; Helicobacter Infections - drug therapy ; Helicobacter Infections - epidemiology ; Helicobacter Infections - etiology ; Helicobacter pylori ; Humans ; Infections ; Levofloxacin ; Lymphoma ; Metronidazole ; Metronidazole - therapeutic use ; Mortality ; Patients ; Poland - epidemiology ; Proton pump inhibitors ; Proton Pump Inhibitors - therapeutic use ; Retrospective Studies ; Ulcers</subject><ispartof>International journal of environmental research and public health, 2022-06, Vol.19 (11), p.6921</ispartof><rights>2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2022 by the authors. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c418t-342acb2ccad6ccbcbaf4b08c9fe5271448bf2f4e97e17e1827bde12147a6613c3</citedby><cites>FETCH-LOGICAL-c418t-342acb2ccad6ccbcbaf4b08c9fe5271448bf2f4e97e17e1827bde12147a6613c3</cites><orcidid>0000-0002-3741-9548 ; 0000-0002-0787-1461 ; 0000-0002-1884-2500 ; 0000-0002-4135-4396 ; 0000-0002-9351-6801</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9180243/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9180243/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35682504$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wasielica-Berger, Justyna</creatorcontrib><creatorcontrib>Gugnacki, Patryk</creatorcontrib><creatorcontrib>Mlynarczyk, Maryla</creatorcontrib><creatorcontrib>Rogalski, Pawel</creatorcontrib><creatorcontrib>Swidnicka-Siergiejko, Agnieszka</creatorcontrib><creatorcontrib>Antonowicz, Stefania</creatorcontrib><creatorcontrib>Krzyzak, Michalina</creatorcontrib><creatorcontrib>Maslach, Dominik</creatorcontrib><creatorcontrib>Dabrowski, Andrzej</creatorcontrib><creatorcontrib>Daniluk, Jaroslaw</creatorcontrib><title>Comparative Effectiveness of Various Eradication Regimens for Helicobacter Pylori Infection in the Northeastern Region of Poland</title><title>International journal of environmental research and public health</title><addtitle>Int J Environ Res Public Health</addtitle><description>Due to the lack of systematic data on antibiotic sensitivity, the treatment of the highly prevalent and pathogenic
(
) infection still poses a significant problem. Therefore, the aim of our study was to compare the efficacy of the three most commonly used anti-
therapies in northeastern Poland.
This was a retrospective, single-center study performed on 289 outpatients with an
infection. Patients received one of the following three treatment regimens: (1) bismuth quadruple therapy (BQT) for 10 days, (2) metronidazole-based triple therapy (M-TT) for 10 or 14 days, and (3) levofloxacin-based triple therapy (L-TT) for 10 or 14 days.
BQT, M-TT, and L-TT accounted for 93.2% of prescribed anti-
therapies. The overall success rate for all treatment regimens was 84.1% (243/289). The effectiveness of first- and second-line therapy was similar and reached 83.8% and 86.2%, respectively. The efficacy of the individual treatment regimens was as follows: (1) BQT-89.4% (84/94), (2) M-TT-80.6% (112/139) and 78.8% (26/33) for 10 and 14 days, respectively, and (3) L-TT-84.6% (11/13) and 100% (10/10) for 10 and 14 days, respectively. The overall duration of treatment and type and dose of proton pump inhibitor (PPI) had no effect on the treatment efficacy.
In the northeastern part of Poland, 10-day BQT and 10- or 14-day L-TT are effective treatment regimens for
eradication and have appear to be superior to M-TT. Practitioners in our clinic followed mostly local anti-
therapy guidelines.</description><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Antibiotics</subject><subject>Antibodies</subject><subject>Antigens</subject><subject>Bacterial infections</subject><subject>Bismuth</subject><subject>Bismuth - therapeutic use</subject><subject>Cancer therapies</subject><subject>Drug Therapy, Combination</subject><subject>Endoscopy</subject><subject>Eradication</subject><subject>Gastric cancer</subject><subject>Gastroenterology</subject><subject>Helicobacter Infections - drug therapy</subject><subject>Helicobacter Infections - epidemiology</subject><subject>Helicobacter Infections - etiology</subject><subject>Helicobacter pylori</subject><subject>Humans</subject><subject>Infections</subject><subject>Levofloxacin</subject><subject>Lymphoma</subject><subject>Metronidazole</subject><subject>Metronidazole - therapeutic use</subject><subject>Mortality</subject><subject>Patients</subject><subject>Poland - epidemiology</subject><subject>Proton pump inhibitors</subject><subject>Proton Pump Inhibitors - therapeutic use</subject><subject>Retrospective Studies</subject><subject>Ulcers</subject><issn>1660-4601</issn><issn>1661-7827</issn><issn>1660-4601</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNpdkctLJDEQxoOs-L56XAJ72ctoXpNOXxZkGB8gKqJeQzpdcTJ0J2PSI3jbP92Mo6JCoArqVx_56kPokJIjzmty7OeQFjNaUyprRjfQDpWSjIQk9NeXfhvt5jwnhCsh6y20zcdSsTERO-j_JPYLk8zgnwFPnQO76gLkjKPDDyb5uMx4mkzrbYFiwLfw6HsIGbuY8Dl03sbG2AESvnnpYvL4IrypFNQHPMwAX8VUismFWa-XURG_iZ0J7T7adKbLcPBe99D96fRucj66vD67mJxcjqygahhxwYxtmLWmldY2tjFONETZ2sGYVVQI1TjmBNQV0PIUq5oWKKOiMlJSbvke-rfWXSybHloLYUim04vke5NedDRef58EP9OP8VnXVBEmeBH4-y6Q4tMS8qB7ny10xQSUG2kmq7EkileqoH9-oPO4TKHYW1GCl8tLWaijNWVTzDmB-_wMJXoVrv4ebln4_dXCJ_6RJn8F3hCkpw</recordid><startdate>20220606</startdate><enddate>20220606</enddate><creator>Wasielica-Berger, Justyna</creator><creator>Gugnacki, Patryk</creator><creator>Mlynarczyk, Maryla</creator><creator>Rogalski, Pawel</creator><creator>Swidnicka-Siergiejko, Agnieszka</creator><creator>Antonowicz, Stefania</creator><creator>Krzyzak, Michalina</creator><creator>Maslach, Dominik</creator><creator>Dabrowski, Andrzej</creator><creator>Daniluk, Jaroslaw</creator><general>MDPI AG</general><general>MDPI</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-3741-9548</orcidid><orcidid>https://orcid.org/0000-0002-0787-1461</orcidid><orcidid>https://orcid.org/0000-0002-1884-2500</orcidid><orcidid>https://orcid.org/0000-0002-4135-4396</orcidid><orcidid>https://orcid.org/0000-0002-9351-6801</orcidid></search><sort><creationdate>20220606</creationdate><title>Comparative Effectiveness of Various Eradication Regimens for Helicobacter Pylori Infection in the Northeastern Region of Poland</title><author>Wasielica-Berger, Justyna ; Gugnacki, Patryk ; Mlynarczyk, Maryla ; Rogalski, Pawel ; Swidnicka-Siergiejko, Agnieszka ; Antonowicz, Stefania ; Krzyzak, Michalina ; Maslach, Dominik ; Dabrowski, Andrzej ; Daniluk, Jaroslaw</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c418t-342acb2ccad6ccbcbaf4b08c9fe5271448bf2f4e97e17e1827bde12147a6613c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Antibiotics</topic><topic>Antibodies</topic><topic>Antigens</topic><topic>Bacterial infections</topic><topic>Bismuth</topic><topic>Bismuth - therapeutic use</topic><topic>Cancer therapies</topic><topic>Drug Therapy, Combination</topic><topic>Endoscopy</topic><topic>Eradication</topic><topic>Gastric cancer</topic><topic>Gastroenterology</topic><topic>Helicobacter Infections - drug therapy</topic><topic>Helicobacter Infections - epidemiology</topic><topic>Helicobacter Infections - etiology</topic><topic>Helicobacter pylori</topic><topic>Humans</topic><topic>Infections</topic><topic>Levofloxacin</topic><topic>Lymphoma</topic><topic>Metronidazole</topic><topic>Metronidazole - therapeutic use</topic><topic>Mortality</topic><topic>Patients</topic><topic>Poland - epidemiology</topic><topic>Proton pump inhibitors</topic><topic>Proton Pump Inhibitors - therapeutic use</topic><topic>Retrospective Studies</topic><topic>Ulcers</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wasielica-Berger, Justyna</creatorcontrib><creatorcontrib>Gugnacki, Patryk</creatorcontrib><creatorcontrib>Mlynarczyk, Maryla</creatorcontrib><creatorcontrib>Rogalski, Pawel</creatorcontrib><creatorcontrib>Swidnicka-Siergiejko, Agnieszka</creatorcontrib><creatorcontrib>Antonowicz, Stefania</creatorcontrib><creatorcontrib>Krzyzak, Michalina</creatorcontrib><creatorcontrib>Maslach, Dominik</creatorcontrib><creatorcontrib>Dabrowski, Andrzej</creatorcontrib><creatorcontrib>Daniluk, Jaroslaw</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of environmental research and public health</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wasielica-Berger, Justyna</au><au>Gugnacki, Patryk</au><au>Mlynarczyk, Maryla</au><au>Rogalski, Pawel</au><au>Swidnicka-Siergiejko, Agnieszka</au><au>Antonowicz, Stefania</au><au>Krzyzak, Michalina</au><au>Maslach, Dominik</au><au>Dabrowski, Andrzej</au><au>Daniluk, Jaroslaw</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparative Effectiveness of Various Eradication Regimens for Helicobacter Pylori Infection in the Northeastern Region of Poland</atitle><jtitle>International journal of environmental research and public health</jtitle><addtitle>Int J Environ Res Public Health</addtitle><date>2022-06-06</date><risdate>2022</risdate><volume>19</volume><issue>11</issue><spage>6921</spage><pages>6921-</pages><issn>1660-4601</issn><issn>1661-7827</issn><eissn>1660-4601</eissn><abstract>Due to the lack of systematic data on antibiotic sensitivity, the treatment of the highly prevalent and pathogenic
(
) infection still poses a significant problem. Therefore, the aim of our study was to compare the efficacy of the three most commonly used anti-
therapies in northeastern Poland.
This was a retrospective, single-center study performed on 289 outpatients with an
infection. Patients received one of the following three treatment regimens: (1) bismuth quadruple therapy (BQT) for 10 days, (2) metronidazole-based triple therapy (M-TT) for 10 or 14 days, and (3) levofloxacin-based triple therapy (L-TT) for 10 or 14 days.
BQT, M-TT, and L-TT accounted for 93.2% of prescribed anti-
therapies. The overall success rate for all treatment regimens was 84.1% (243/289). The effectiveness of first- and second-line therapy was similar and reached 83.8% and 86.2%, respectively. The efficacy of the individual treatment regimens was as follows: (1) BQT-89.4% (84/94), (2) M-TT-80.6% (112/139) and 78.8% (26/33) for 10 and 14 days, respectively, and (3) L-TT-84.6% (11/13) and 100% (10/10) for 10 and 14 days, respectively. The overall duration of treatment and type and dose of proton pump inhibitor (PPI) had no effect on the treatment efficacy.
In the northeastern part of Poland, 10-day BQT and 10- or 14-day L-TT are effective treatment regimens for
eradication and have appear to be superior to M-TT. Practitioners in our clinic followed mostly local anti-
therapy guidelines.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>35682504</pmid><doi>10.3390/ijerph19116921</doi><orcidid>https://orcid.org/0000-0002-3741-9548</orcidid><orcidid>https://orcid.org/0000-0002-0787-1461</orcidid><orcidid>https://orcid.org/0000-0002-1884-2500</orcidid><orcidid>https://orcid.org/0000-0002-4135-4396</orcidid><orcidid>https://orcid.org/0000-0002-9351-6801</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1660-4601 |
| ispartof | International journal of environmental research and public health, 2022-06, Vol.19 (11), p.6921 |
| issn | 1660-4601 1661-7827 1660-4601 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9180243 |
| source | MDPI - Multidisciplinary Digital Publishing Institute; MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central; Free Full-Text Journals in Chemistry; PubMed Central Open Access |
| subjects | Anti-Bacterial Agents - pharmacology Antibiotics Antibodies Antigens Bacterial infections Bismuth Bismuth - therapeutic use Cancer therapies Drug Therapy, Combination Endoscopy Eradication Gastric cancer Gastroenterology Helicobacter Infections - drug therapy Helicobacter Infections - epidemiology Helicobacter Infections - etiology Helicobacter pylori Humans Infections Levofloxacin Lymphoma Metronidazole Metronidazole - therapeutic use Mortality Patients Poland - epidemiology Proton pump inhibitors Proton Pump Inhibitors - therapeutic use Retrospective Studies Ulcers |
| title | Comparative Effectiveness of Various Eradication Regimens for Helicobacter Pylori Infection in the Northeastern Region of Poland |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T14%3A04%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparative%20Effectiveness%20of%20Various%20Eradication%20Regimens%20for%20Helicobacter%20Pylori%20Infection%20in%20the%20Northeastern%20Region%20of%20Poland&rft.jtitle=International%20journal%20of%20environmental%20research%20and%20public%20health&rft.au=Wasielica-Berger,%20Justyna&rft.date=2022-06-06&rft.volume=19&rft.issue=11&rft.spage=6921&rft.pages=6921-&rft.issn=1660-4601&rft.eissn=1660-4601&rft_id=info:doi/10.3390/ijerph19116921&rft_dat=%3Cproquest_pubme%3E2675608378%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2674350466&rft_id=info:pmid/35682504&rfr_iscdi=true |